piracetam has been researched along with Adrenal Cancer in 1 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| von Krogh, K | 1 |
| Harjen, H | 1 |
| Almås, C | 1 |
| Zimmer, KE | 1 |
| Dahl, E | 1 |
| Olsaker, I | 1 |
| Taubøll, E | 1 |
| Ropstad, E | 1 |
| Verhaegen, S | 1 |
1 other study available for piracetam and Adrenal Cancer
| Article | Year |
|---|---|
The effect of valproate and levetiracetam on steroidogenesis in forskolin-stimulated H295R cells.
Topics: Adrenal Gland Neoplasms; Anticonvulsants; Aromatase; Cell Line, Tumor; Colforsin; Cytochrome P-450 C | 2010 |